Ranibizumab for choroidal neovascularization secondary to pseudoxanthoma elasticum: 4-year results from the PIXEL study in France
Crossref DOI link: https://doi.org/10.1007/s00417-017-3685-y
Published Online: 2017-05-10
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mimoun, GĂ©rard
Ebran, Jean-Marc
Grenet, Typhaine
Donati, Alain
Cohen, Salomon-Yves
Ponthieux, Anne
Funding for this research was provided by:
Novartis Pharma SAS, Rueil-Malmaison, France
License valid from 2017-05-10